MedTrace Logo MedTrace
Clinical Trials News Drugs Diseases Companies About

NKTR-255

  1. Home
  2. Drugs
  3. NKTR-255
  4. Clinical Trials

Clinical Trials Related to NKTR-255

Related studies linked through entity extraction aliases.

NCT05632809

REStoring lymphoCytes Using NKTR-255* After chemoradiothErapy in Solid Tumors (RESCUE)

Status
RECRUITING
Phase
PHASE2

NCT05327530

A Study of the Safety and Efficacy of Various Combinations of Avelumab as Therapy in Locally Advanced or Metastatic Urothelial Carcinoma (JAVELIN Bladder Medley)

Status
ACTIVE_NOT_RECRUITING
Phase
PHASE2

NCT04616196

Study of NKTR 255 in Combination With Cetuximab in Solid Tumors

Status
COMPLETED
Phase
PHASE1/PHASE2

NCT04136756

NKTR-255 in Relapsed/Refractory Multiple Myeloma & Non-Hodgkin Lymphoma

Status
COMPLETED
Phase
PHASE1

NCT03233854

CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells With or Without NKTR-255 in Adults With Recurrent or Refractory B Cell Malignancies

Status
ACTIVE_NOT_RECRUITING
Phase
PHASE1

Clinical Trials

Explore studies by the year of their last update.

  • 2026
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005

News & Analysis

Latest news and insights on clinical trials and medical research.

Browse All News →
MedTrace Logo MedTrace
About Privacy Policy Terms of Service Medical Disclaimer

© 2026 MedTrace.
Open-access medical & pharmaceutical data intelligence.